Pharmalicensing brings you advice, commentary and analysis from industry experts.
Drug & Market Development Newsletter is published twelve times each year. The newsletter provides in-depth reviews of current R&D developments in the pharmaceutical and biotechnology industries.
Drug & Market Development Publications, a division of
plc, publishes D&MD Newsletter and D&MD Reports. Our publications are designed to bring detailed,
business and technology information to pharmaceutical and
biotechnology executives working in R&D, business
marketing. D&MD Newsletter is monthly newsletter designed to help
R&D developments and asses market trends of the
and biotechnology field, featuring regular features on: * Technology & Strategy Issues * Industry Meetings * Therapeutic & Market Updates * Cardiovascular & Blood-related Diseases * Central Nervous Systems * Inflammatory & Infectious Diseases * Cancer * International Issues * Company Profiles D&MD Reports are in-depth market research reports that
feature: * Comprehensive summaries and analysis of markets * In-depth profiles of leading companies and alliances * Reviews of key trends and market drivers * Implications for long term profit potential * Availability in CD-ROM and print formats Recent titles include: Overcoming Formulations Challenges,
Genomics, Pain Therapeutics, GPCRs, Nanobiotechnology,
Opportunities in Enzyme Technologies, Generic Drugs,
Therapeutics, Transgenic Plants. Drug & Market Development Publications
One Research Drive,
P.O. Box 5194,
USA 508-616-5566 (phone) 508-616-5544 (fax)
Clients in focus...